Corrigendum to “Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis”

Table 3

Short and long-term outcome after aSAH.

Comparison groups		N total; Group A + B	Odds ratio for poor outcome; Group A/B	Z		Heterogeneity
Group A	Group B					Chi^2	Df	I^2
Short-term outcome
Hp2-2	Hp1-1	192 (132 + 60)	2.37 (1.12, 5.04)	2.26	0.02	3.93	3	24%
Hp2-1	Hp1-1	228 (168 + 60)	1.53 (0.74, 3.14)	1.16	0.25	5.92	4	32%
Hp2-2	Hp2-1	300 (132 + 168)	1.90 (1.11, 3.25)	2.34	0.02	1.79	4	0%
Hp2-2	Hp1-1 & Hp2-1	360 (132 + 228)	2.07 (1.26, 3.41)	2.87	0.004	1.77	4	0%
Hp2-1 & Hp2-2	Hp1-1	360 (300 + 60)	1.96 (0.99, 3.86)	1.94	0.05	5.11	4	22%
Long-term outcome
Hp2-2	Hp1-1	216 (155 + 61)	1.61 (0.81, 3.16)	1.37	0.17	4.96	2	60%
Hp2-1	Hp1-1	266 (205 + 61)	1.28 (0.65, 2.51)	0.72	0.47	3.58	2	44%
Hp2-2	Hp2-1	360 (155 + 205)	1.34 (0.85, 2.10)	1.27	0.20	0.55	2	0%
Hp2-2	Hp1-1 & Hp2-1	421 (155 + 266)	1.37 (0.89, 2.10)	1.44	0.15	1.55	2	0%
Hp2-1 & Hp2-2	Hp1-1	421 (360 + 61)	1.41 (0.75, 2.65)	1.06	0.29	4.26	2	53%

; Z: test for overall effect.